​

CONMED (CNMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CNMD Stock Forecast

CONMED (CNMD) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $97.00, with a high of $97.00 and a low of $97.00. This represents a 37.80% increase from the last price of $70.39.

$65 $74 $83 $92 $101 $110 High: $97 Avg: $97 Low: $97 Last Closed Price: $70.39

CNMD Stock Rating

CONMED stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

CNMD Forecast vs Benchmarks

TypeNameUpside
StockCONMED37.80%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$99.67
Last Closing Price$70.39$70.39$70.39
Upside/Downside--41.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25313--7
Dec, 24413--8
Nov, 24424--10
Oct, 24444--12
Sep, 24444--12
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 04, 2024Mike MatsonNeedham$97.00$66.5945.67%37.80%
Apr 25, 2024Matt O\'BrienPiper Sandler$95.00$64.3447.65%34.96%
Apr 25, 2024Mike MatsonNeedham$107.00$70.0152.84%52.01%
Oct 26, 2022Matt O'BrienPiper Sandler$108.00$83.3929.51%53.43%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 04, 2024Piper SandlerUnderperformUnderperformhold
Oct 04, 2024NeedhamBuyBuyhold
Aug 01, 2024Wells FargoBuyBuyhold
Apr 25, 2024Piper SandlerOverweightOverweighthold
Apr 25, 2024NeedhamBuyBuyhold
Feb 01, 2024Wells FargoEqual-WeightEqual-Weighthold
Feb 01, 2024NeedhamBuyBuyhold
Apr 27, 2023NeedhamBuyBuyhold
Mar 27, 2023KeyBancOverweightupgrade
Feb 02, 2023Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.33$2.14$-2.50$2.04----
Avg Forecast$2.10$3.17$3.12$3.50$4.03$4.74$5.63$5.58
High Forecast$2.06$3.12$3.08$3.49$4.00$4.50$5.40$5.46
Low Forecast$2.13$3.21$3.15$3.55$4.04$5.02$5.85$5.65
Surprise %-84.29%-32.49%-180.13%-41.71%----

Revenue Forecast

$850M $1B $1B $1B $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$862.46M$1.01B$1.05B$1.24B----
Avg Forecast$872.65M$1.01B$1.10B$1.25B$1.30B$1.40B$1.50B$1.54B
High Forecast$860.85M$998.88M$1.09B$1.23B$1.28B$1.38B$1.50B$1.52B
Low Forecast$881.40M$1.02B$1.10B$1.26B$1.32B$1.41B$1.50B$1.56B
Surprise %-1.17%-0.19%-4.71%-0.42%----

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$9.52M$62.54M$-80.58M$64.46M----
Avg Forecast$-9.36M$54.97M$-111.81M$64.46M$126.72M$150.14M$177.49M$176.04M
High Forecast$-26.49M$43.98M$-155.87M$38.38M$126.09M$141.89M$170.29M$172.31M
Low Forecast$7.77M$65.96M$-67.76M$90.54M$127.35M$158.40M$184.69M$178.33M
Surprise %-201.64%13.78%-27.93%-----

CNMD Forecast FAQ

Is CONMED stock a buy?

CONMED stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CONMED is a favorable investment for most analysts.

What is CONMED's price target?

CONMED's price target, set by 3 Wall Street analysts, averages $97 over the next 12 months. The price target range spans from $97 at the low end to $97 at the high end, suggesting a potential 37.80% change from the previous close price of $70.39.

How does CONMED stock forecast compare to the average forecast of its sector, industry, and investment themes?

CONMED stock forecast shows a 37.80% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for CONMED over the past three months?

  • January 2025: 42.86% Strong Buy, 14.29% Buy, 42.86% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 50.00% Strong Buy, 12.50% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is CONMED’s EPS forecast?

CONMED's average annual EPS forecast for its fiscal year ending in December is 4.03 for 2024, a 97.55% increase from the reported $2.04 in 2023. The prediction for 2025 is $4.74, $5.63 for 2026, and $5.58 for 2027.

What is CONMED’s revenue forecast?

CONMED's average annual revenue forecast for its fiscal year ending in December is $1.3B for 2024, a 4.61% increase from the reported $1.24B in 2023. The forecast for 2025 is $1.4B, $1.5B for 2026, and $1.54B for 2027.

What is CONMED’s net income forecast?

For its fiscal year ending in December, CONMED's average annual net income forecast is $126.72M for 2024, reflecting an 96.58% increase from the reported $64.46M in 2023. The projection for 2025 is $150.14M, $177.49M for 2026, and $176.04M for 2027.